ProQR Therapeutics (PRQR) Assets Average (2022 - 2025)

ProQR Therapeutics' Assets Average history spans 3 years, with the latest figure at $163.9 million for Q4 2024.

  • For Q4 2024, Assets Average rose 1.45% year-over-year to $163.9 million; the TTM value through Dec 2024 reached $163.9 million, up 1.45%, while the annual FY2024 figure was $165.5 million, 0.37% changed from the prior year.
  • Assets Average for Q4 2024 was $163.9 million at ProQR Therapeutics, up from $161.6 million in the prior quarter.
  • Across five years, Assets Average topped out at $207.3 million in Q4 2022 and bottomed at $161.6 million in Q4 2023.
  • The 3-year median for Assets Average is $163.9 million (2024), against an average of $177.6 million.
  • The largest annual shift saw Assets Average fell 22.05% in 2023 before it rose 1.45% in 2024.
  • A 3-year view of Assets Average shows it stood at $207.3 million in 2022, then decreased by 22.05% to $161.6 million in 2023, then rose by 1.45% to $163.9 million in 2024.
  • Per Business Quant, the three most recent readings for PRQR's Assets Average are $163.9 million (Q4 2024), $161.6 million (Q4 2023), and $207.3 million (Q4 2022).